Singapore-based healthtech startup Injewelme has raised $1.2 million in a funding round to propel its AI-driven health monitoring innovations.
The pre-seed round was anchored by Temasek Trust's C3H (Catalytic Capital for Climate and Health) and joined by the UK-based Richardson Family office.
Injewelme's Breakthrough Technology
The investment will fuel the advancement of Injewelme's DeepHealthVision (DHV) platform, a contactless AI system for real-time health assessment.
DHV technology leverages computer vision to detect early signs of climate-related health risks without the need for wearables or invasive devices.
This approach marks a shift from traditional monitoring methods, enhancing accessibility in remote or underserved areas.
Broader Impact and Market Context
Injewelme's focus on preventive care aligns with rising global concerns over health vulnerabilities exacerbated by climate change.
The startup, emerging from Singapore's thriving healthtech scene, builds on years of AI research tailored for healthcare applications.
Key investors highlighted the potential for DHV to scale rapidly and integrate into public health infrastructures.
Looking ahead, Injewelme plans to expand DHV's capabilities to monitor additional vital signs and vital parameters.
This funding underscores Singapore's role as a hub for innovative healthtech addressing future challenges.
With enhanced resources, Injewelme is set to lead in AI-powered, equitable health solutions worldwide.
Maria Lourdes
